BB Biotech is a long-standing player in the biotechnology investment sector, boasting more than 30 years of experience in the field. Its slogan, "Your access to fast growing biotech companies since 1993," underlines its commitment to identifying and nurturing promising ventures in the biotech space.
The company's primary focus is on investing in listed businesses that are dedicated to developing and bringing to market innovative pharmaceuticals, which provide significant value to the healthcare system.
BB Biotech's shares are publicly listed on the SIX Swiss Exchange, the Frankfurt Stock Exchange, and the Stock Exchange in Milan, reflecting its transparent and well-established presence in the market.
Founded in 1993, BB Biotech has emerged as one of the largest investors globally in the biotechnology sector, solidifying its reputation as a reliable and seasoned investment partner for biotech startups and established companies alike.
Given its extensive track record, BB Biotech represents a compelling option for venture capital firms seeking to engage with a reputable and experienced player in the biotech investment landscape.
There is no investment information
No recent news or press coverage available for BB Biotech.